Cargando…
THU487 Xenograft of VHL-deficient Pancreatic Neuroendocrine Neoplasm Cells - A Novel Low-grade PNEN In Vivo Model
Disclosure: A. Telerman: None. Y. Yossef: None. A. Chmelnik: None. A. Tirosh: None. Background: Von Hippel-Lindau (VHL) disease is a familial cancer syndrome caused by a germline mutation in the VHL tumor suppressor gene. Although VHL-related pancreatic neuroendocrine neoplasms (vPNEN) have been stu...
Autores principales: | Telerman, Alona, Yossef, Yuval, Chmelnik, Adiel, Tirosh, Amit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553709/ http://dx.doi.org/10.1210/jendso/bvad114.2115 |
Ejemplares similares
-
THU494 VHL Protein Deficiency Alters The Immune Microenvironment Of Pancreatic Neuroendocrine Neoplasms
por: Chmelnik, Adiel, et al.
Publicado: (2023) -
THU508 Does Mid-treatment Response To 177Lu-DOTATATE Predict Treatment Outcome In Patients With Neuroendocrine Neoplasms?
por: Halperin, Reut, et al.
Publicado: (2023) -
THU541 Impact Of Gender On Treatment Decisions And Outcome In Patients With Neuroendocrine Neoplasms
por: Beck, Julia, et al.
Publicado: (2023) -
THU528 ACTH-dependent Hypercortisolism From Neuroendocrine Prostate Tumor With Negative ACTH Staining Of The Tumor Cells
por: Fariduddin, Maria, et al.
Publicado: (2023) -
THU521 A Case Of Multifocal Pancreatic Neuroendocrine Tumor With Multiple Twists
por: Syeda, Asma, et al.
Publicado: (2023)